- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: November 2016
- Public Summary Document (PSD) November 2016 PBAC Meeting - PDF
- Public Summary Document (PSD) November 2016 PBAC Meeting - Word
Netupitant with palonosetron – November 2016
Netupitant with palonosetron: Capsule containing netupitant 300 mg with palonosetron 500 microgram (as hydrochloride); Akynzeo®
Last updated
3 March 2017